Loading stock data…
Guardant Health (GH)
$150.38+1.16 (+0.78%)
Market OpenUpdated 11:20 AM EDT
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Guardant Health, Inc. in the Healthcare sector is trading at $152.16 with a market capitalization of $17.3B. Wall Street consensus targets $144.42 (24 analysts), implying a -5.1% move over the next 12 months. The stock is currently near its 52-week high of $153.00, remaining 58.0% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply -5.1% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $301.67M↑ | $281.27M↑ | $265.20M↑ | $232.09M↑ | $203.47M |
| Gross Profit | $196.75M↑ | $181.77M↑ | $171.61M↑ | $150.88M↑ | $128.75M |
| Operating Income | -$121.35M↓ | -$120.81M↓ | -$98.99M↑ | -$106.41M↑ | -$111.04M |
| Net Income | -$112.08M↑ | -$128.49M↓ | -$92.72M↑ | -$99.90M↓ | -$95.16M |
Peer Comparison
JNJUNHPFE
Fundamentals
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liqu...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$17.29B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
239.24%
Volume
Today's trading volume
800,451
Recent News
Why Are Guardant Health (GH) Shares Soaring Today
Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 5.4% in the afternoon session after several investment firms issued positive ratings, citing the recent FDA approval for the company's G360 assay.
Dow Jones Futures Rise As Micron Earnings Send Sandisk, Techs Soaring; Fed Inflation Data Due
Micron surged overnight on strong earnings and guidance, lifting other memory and chip plays. The Fed's favorite inflation gauge is on tap.
Dow Jones Futures: Nasdaq Set To Regain Key Level As Korea's Kospi Rebounds, Micron Due; FedEx, Cerebras Tumble
Tech stocks rebounded with South Korea's Kospi index after the Nasdaq broke key support Tuesday. Micron earnings loom. FedEx and AI chip IPO Cerebras dived late.
3 Russell 2000 Stocks We Approach with Caution
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
Living Longer Is Big Business. These Stocks Will Benefit.
TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion.